Skip to content

Biogen BIIB LUNSUMIO — After Second GAZYVA Threshold Date

Similar metrics at other companies

BGC Group, Inc. logo
BGC2030 and 2031
$1.66B+76.9%
Hercules Capital logo
HTGC2030 and 2031
$857.8M+55.1%
Sphere Entertainment logo
SPHRSphere — Year ending December 31, 2029
$0
Alkermes logo
ALKSLUMRYZ — Revenue
$39.49M
Sphere Entertainment logo
SPHRSphere — Year ending December 31, 2030
$0
Royalty Pharma logo
RPRXTrelegy — Milestone payable
$12.5M0.0%

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Operating income$610.7M
Net income$319.5M+32.8%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$31.89B+72.3%
Enterprise value$35.07B+57.0%
P/E22.5×+10.4×
P/S3.2×+1.4×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp
FCF margin24.4%-0.4pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept biib:PercentageOfCoPromotionOperatingProfitsGreaterThanFirstFiftyMillionOptionTwoSubOptionThree.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's lunsumio — after second gazyva threshold date.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's LUNSUMIO — after second GAZYVA threshold date?
Biogen (BIIB) reported LUNSUMIO — after second GAZYVA threshold date of 35% in Q1 2026.
What does LUNSUMIO — after second GAZYVA threshold date mean?
This metric identifies the temporal milestone occurring after a secondary performance threshold related to the Gazyva product has been reached. It marks a transition point in the collaboration agreement where financial or operational terms for Lunsumio may change. It is essential for tracking the lifecycle of the partnership and the evolution of profit-sharing dynamics.